Last update 22 May 2025

NK-520

Overview

Basic Info

Drug Type
Natural Killer Cell Therapies
Synonyms
NK 520, NK520
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Refractory acute myeloid leukemiaRelapsing acute myeloid leukemiaAcute Myeloid Leukemia
Inactive Indication
Ovarian Cancer
Originator Organization
Base Therapeutics (Zhuhai) Ltd.Base Therapeutics (Zhuhai) Ltd.
Active Organization
Base Therapeutics (Shanghai) Ltd.Base Therapeutics (Zhuhai) Ltd.Base Therapeutics (Zhuhai) Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with NK-520
NCT06541405
/ RecruitingEarly Phase 1
An Open, Single Center Exploratory Study to Evaluate Safety and Efficacy of NK520 for Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT06541444
/ RecruitingEarly Phase 1
An Open, Single Center Exploratory Study to Evaluate Safety and Efficacy of NK520 for Patients With Relapsed/Refractory Acute Myeloid Leukemia
100 Clinical Results associated with NK-520
Login to view more data
100 Translational Medicine associated with NK-520
Login to view more data
100 Patents (Medical) associated with NK-520
Login to view more data
100 Deals associated with NK-520
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaPhase 1
China
Base Therapeutics (Shanghai) Ltd.
01 Jul 2024
Relapsing acute myeloid leukemiaPhase 1
China
Base Therapeutics (Shanghai) Ltd.
01 Jul 2024
Acute Myeloid LeukemiaPreclinical
China
Base Therapeutics (Zhuhai) Ltd.Base Therapeutics (Zhuhai) Ltd.
07 Nov 2023
Ovarian CancerPreclinical
China
Base Therapeutics (Zhuhai) Ltd.Base Therapeutics (Zhuhai) Ltd.
07 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free